Related Experiment Video
Updated: Feb 19, 2026
The Measurement and Treatment of Suppression in Amblyopia
Published on: December 14, 2012
[The Use of a Microsensor in Therapy of Amblyopia]
Kai Januschowski1, Annekatrin Rickmann2, Caroline Emmerich2
1Augenheilkunde, Universitätsaugenklinik, Eberhard-Karls-Universität Tübingen, Tübingen.
Insights
A new TheraMon microsensor objectively tracks amblyopia (lazy eye) treatment compliance by monitoring patch wear time. This technology can improve occlusion therapy protocols for better visual outcomes in children.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Biomedical Engineering
Background:
- Amblyopia, or lazy eye, is a common childhood visual disorder.
- Current treatment involves occlusion therapy, which requires high patient compliance for success.
Purpose of the Study:
- To evaluate the TheraMon microsensor's utility in objectively monitoring compliance with occlusion therapy for amblyopia.
- To explore how objective compliance data can inform improved treatment protocols.
Main Methods:
- Utilized the TheraMon microsensor, a small device that records ambient temperature at regular intervals.
- Analyzed temperature data to determine the duration and consistency of patch application.
Main Results:
- The TheraMon microsensor successfully documented the application time of occlusion patches.
- Objective data on wear time can be derived from the sensor's temperature recordings.
Conclusions:
- The TheraMon microsensor offers a reliable method for objective compliance monitoring in amblyopia treatment.
- This technology has the potential to enhance the effectiveness of occlusion therapy by optimizing application protocols.
Abstract:
Amblyopia is one of the most common visual disorders in children. Current therapy of amblyopia is an occlusion therapy of the stronger eye with an occlusion patch until the best corrected visual acuity is achieved. The success of occlusion therapy essentially depends on the compliance of the children and their parents. There is a commercially available 8 × 12 mm small TheraMon microsensor (TheraMon-Chip, MC Technology GmbH). This sensor allows a simple objective documentation of the therapy compliance of patches and glasses. It samples the surrounding temperature in regular intervals. Due to the specific temperatures, it is possible to detect the time of application and, therefore, the compliance. Therefore, TheraMon microsensor could be a study-related approach for monitoring the compliance and further leading to possible improvement of application time protocols in amblyopia therapy.
